These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14499182)

  • 1. A computationally derived structural model of doxorubicin interacting with oligomeric polyalkylcyanoacrylate in nanoparticles.
    Poupaert JH; Couvreur P
    J Control Release; 2003 Sep; 92(1-2):19-26. PubMed ID: 14499182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the use of ion-pair chromatography to elucidate doxorubicin release mechanism from polyalkylcyanoacrylate nanoparticles at the cellular level.
    Pepin X; Attali L; Domrault C; Gallet S; Metreau JM; Reault Y; Cardot PJ; Imalalen M; Dubernet C; Soma E; Couvreur P
    J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):181-91. PubMed ID: 9449570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.
    Soma CE; Dubernet C; Bentolila D; Benita S; Couvreur P
    Biomaterials; 2000 Jan; 21(1):1-7. PubMed ID: 10619673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles.
    Alhareth K; Vauthier C; Gueutin C; Ponchel G; Moussa F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():128-32. PubMed ID: 22341684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.
    de Verdière AC; Dubernet C; Némati F; Soma E; Appel M; Ferté J; Bernard S; Puisieux F; Couvreur P
    Br J Cancer; 1997; 76(2):198-205. PubMed ID: 9231919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(styrene-alt-maleic anhydride)-based diblock copolymer micelles exhibit versatile hydrophobic drug loading, drug-dependent release, and internalization by multidrug resistant ovarian cancer cells.
    Baranello MP; Bauer L; Benoit DS
    Biomacromolecules; 2014 Jul; 15(7):2629-41. PubMed ID: 24955779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study.
    Gallois L; Fiallo M; Garnier-Suillerot A
    Biochim Biophys Acta; 1998 Mar; 1370(1):31-40. PubMed ID: 9518541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An interpretative analysis of the effect of the surfactants used for the preparation of polyalkylcyanoacrylate nanoparticles on the release process.
    Vandelli MA; Fresta M; Puglisi G; Forni F
    J Microencapsul; 1994; 11(5):531-8. PubMed ID: 7815270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.
    Calvo P; Gouritin B; Villarroya H; Eclancher F; Giannavola C; Klein C; Andreux JP; Couvreur P
    Eur J Neurosci; 2002 Apr; 15(8):1317-26. PubMed ID: 11994126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles.
    Peracchia MT; Harnisch S; Pinto-Alphandary H; Gulik A; Dedieu JC; Desmaële D; d'Angelo J; Müller RH; Couvreur P
    Biomaterials; 1999 Jul; 20(14):1269-75. PubMed ID: 10403044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate.
    Lai P; Daear W; Löbenberg R; Prenner EJ
    Colloids Surf B Biointerfaces; 2014 Jun; 118():154-63. PubMed ID: 24769392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of cyclodextrins in the formulation of polyalkylcyanoacrylate nanoparticles charged with different active ingredients].
    Duchêne D; Ponchel G; Boudad H; da Silveira AM
    Ann Pharm Fr; 2001 Nov; 59(6):384-91. PubMed ID: 11924510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles.
    Verdun C; Brasseur F; Vranckx H; Couvreur P; Roland M
    Cancer Chemother Pharmacol; 1990; 26(1):13-8. PubMed ID: 2322986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Peptide Polymer Interactions in Poly(alkylcyanoacrylate) Nanoparticles: A Mass Spectrometric Approach.
    Kafka AP; Kleffmann T; Rades T; McDowell A
    Curr Drug Deliv; 2010 Jul; 7(3):208-15. PubMed ID: 20497104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of a linoleic-acid-modified amphiphilic polypeptide copolymer as a carrier for controlled drug release.
    Tian Z; Zhang AY; Ye L; Wang M; Feng ZG
    Biomed Mater; 2008 Dec; 3(4):044116. PubMed ID: 19029601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of honeycomb-patterned polyalkylcyanoacrylate films from monomer solution by breath figures method.
    Li X; Wang Y; Zhang L; Tan S; Yu X; Zhao N; Chen G; Xu J
    J Colloid Interface Sci; 2010 Oct; 350(1):253-9. PubMed ID: 20637473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Targeting bone marrow with the help of polyalkylcyanoacrylate nanoparticles].
    Gibaud S; Weingarten C; Andreux JP; Couvreur P
    Ann Pharm Fr; 1999 Jul; 57(4):324-31. PubMed ID: 10472705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of antitumor drug Doxorubicin and its analogue by chitosan nanoparticles.
    Sanyakamdhorn S; Agudelo D; Tajmir-Riahi HA
    Biomacromolecules; 2013 Feb; 14(2):557-63. PubMed ID: 23305154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformation of surface-decorating dextran chains affects the pharmacokinetics and biodistribution of doxorubicin-loaded nanoparticles.
    Alhareth K; Vauthier C; Bourasset F; Gueutin C; Ponchel G; Moussa F
    Eur J Pharm Biopharm; 2012 Jun; 81(2):453-7. PubMed ID: 22465096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of polyalkylcyanoacrylate nanoparticles as a potential drug carrier: preparation, morphological characterization and loading capacity.
    Puglisi G; Giammona G; Fresta M; Carlisi B; Micali N; Villari A
    J Microencapsul; 1993; 10(3):353-66. PubMed ID: 8377093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.